Wafa Harrouk

1.2k total citations
26 papers, 785 citations indexed

About

Wafa Harrouk is a scholar working on Molecular Biology, Cancer Research and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Wafa Harrouk has authored 26 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Wafa Harrouk's work include Carcinogens and Genotoxicity Assessment (8 papers), Pluripotent Stem Cells Research (7 papers) and Effects and risks of endocrine disrupting chemicals (6 papers). Wafa Harrouk is often cited by papers focused on Carcinogens and Genotoxicity Assessment (8 papers), Pluripotent Stem Cells Research (7 papers) and Effects and risks of endocrine disrupting chemicals (6 papers). Wafa Harrouk collaborates with scholars based in United States, Canada and United Kingdom. Wafa Harrouk's co-authors include Barbara F. Hales, Frederick A. Beland, Robin L. Stingley, Jia‐Long Fang, Bernard Robaire, Paul C. Howard, Hugh J. Clarke, Robert K. Vinson, Jens Mortensen and Warren Harvey and has published in prestigious journals such as Environmental Health Perspectives, Biology of Reproduction and Toxicological Sciences.

In The Last Decade

Wafa Harrouk

25 papers receiving 762 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wafa Harrouk United States 15 249 209 152 86 82 26 785
Amar V. Singh United States 14 472 1.9× 408 2.0× 84 0.6× 195 2.3× 74 0.9× 30 1.3k
Jackye Peretz United States 16 175 0.7× 938 4.5× 187 1.2× 135 1.6× 162 2.0× 20 1.4k
Costanza Rovida Italy 16 191 0.8× 368 1.8× 164 1.1× 68 0.8× 63 0.8× 32 1.2k
Zhanquan Shi United States 19 269 1.1× 195 0.9× 103 0.7× 182 2.1× 13 0.2× 40 938
Tzutzuy Ramı́rez Germany 18 402 1.6× 205 1.0× 190 1.3× 86 1.0× 37 0.5× 25 1.4k
Diane M. Klotz United States 11 301 1.2× 158 0.8× 57 0.4× 80 0.9× 41 0.5× 20 839
Dushyant Gulati United States 15 223 0.9× 424 2.0× 116 0.8× 432 5.0× 42 0.5× 48 904
Gary J. Overmann United States 13 345 1.4× 382 1.8× 36 0.2× 62 0.7× 17 0.2× 15 824
Jae‐Ho Shin South Korea 16 138 0.6× 321 1.5× 46 0.3× 78 0.9× 33 0.4× 33 710
Fiona Sewell United Kingdom 16 120 0.5× 172 0.8× 44 0.3× 40 0.5× 59 0.7× 41 733

Countries citing papers authored by Wafa Harrouk

Since Specialization
Citations

This map shows the geographic impact of Wafa Harrouk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wafa Harrouk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wafa Harrouk more than expected).

Fields of papers citing papers by Wafa Harrouk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wafa Harrouk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wafa Harrouk. The network helps show where Wafa Harrouk may publish in the future.

Co-authorship network of co-authors of Wafa Harrouk

This figure shows the co-authorship network connecting the top 25 collaborators of Wafa Harrouk. A scholar is included among the top collaborators of Wafa Harrouk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wafa Harrouk. Wafa Harrouk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonzo, Jessica A., Todd Bourcier, Ikram Elayan, et al.. (2020). An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs). Regulatory Toxicology and Pharmacology. 114. 104662–104662. 112 indexed citations
2.
Nakamura, Noriko, Vikrant Vijay, Varsha G. Desai, et al.. (2018). Transcript profiling in the testes and prostates of postnatal day 30 Sprague-Dawley rats exposed prenatally and lactationally to 2-hydroxy-4-methoxybenzophenone. Reproductive Toxicology. 82. 111–123. 5 indexed citations
3.
Chen, Xinrong, Tao Han, J. Edward Fisher, et al.. (2017). Transcriptomics analysis of early embryonic stem cell differentiation under osteoblast culture conditions: Applications for detection of developmental toxicity. Reproductive Toxicology. 69. 75–83. 2 indexed citations
4.
Chen, Xinrong, Deborah K. Hansen, Greg T. Nolen, et al.. (2015). Developing osteoblasts as an endpoint for the mouse embryonic stem cell test. Reproductive Toxicology. 53. 131–140. 8 indexed citations
5.
Struble, Evi, Wafa Harrouk, Albert DeFelice, & Belay Tesfamariam. (2015). Nonclinical aspects of venous thrombosis in pregnancy. Birth Defects Research Part C Embryo Today Reviews. 105(3). 190–200. 7 indexed citations
6.
Shen, Jie, Lei Xu, Hong Fang, et al.. (2013). EADB: An Estrogenic Activity Database for Assessing Potential Endocrine Activity. Toxicological Sciences. 135(2). 277–291. 56 indexed citations
7.
Inselman, Amy L., Greg T. Nolen, Ching‐Wei Chang, et al.. (2013). Reevaluation of the Embryonic Stem Cell Test. 1(1). 32–49. 1 indexed citations
8.
Brannen, Kimberly, Suzanne E. Fenton, Deborah K. Hansen, et al.. (2011). Developmental toxicology—new directions workshop: refining testing strategies and study designs. Birth Defects Research Part B Developmental and Reproductive Toxicology. 92(5). 404–412. 14 indexed citations
9.
Makris, Susan L., James H. Kim, Amy Ellis, et al.. (2011). Current and future needs for developmental toxicity testing. Birth Defects Research Part B Developmental and Reproductive Toxicology. 92(5). 384–394. 16 indexed citations
10.
Fang, Jia‐Long, et al.. (2010). Occurrence, Efficacy, Metabolism, and Toxicity of Triclosan. Journal of Environmental Science and Health Part C. 28(3). 147–171. 168 indexed citations
11.
Beyer, Bruce, Neil Chernoff, Bengt Danielsson, et al.. (2010). ILSI/HESI maternal toxicity workshop summary: maternal toxicity and its impact on study design and data interpretation. Birth Defects Research Part B Developmental and Reproductive Toxicology. 92(1). 36–51. 45 indexed citations
12.
Harrouk, Wafa, et al.. (2005). Effects of hyperthermia and boric acid on skeletal development in rat embryos. Birth Defects Research Part B Developmental and Reproductive Toxicology. 74(3). 268–276. 9 indexed citations
13.
Leighton, John K., Paul C. Brown, Amy Ellis, et al.. (2005). Workgroup Report: Review of Genomics Data Based on Experience with Mock Submissions—View of the CDER Pharmacology Toxicology Nonclinical Pharmacogenomics Subcommittee. Environmental Health Perspectives. 114(4). 573–578. 17 indexed citations
14.
Harrouk, Wafa, et al.. (2002). Buthionine sulfoximine embryotoxicity is associated with prolonged AP‐1 activation. Teratology. 66(4). 192–200. 11 indexed citations
15.
Harrouk, Wafa, Bernard Robaire, & Barbara F. Hales. (2000). Paternal Exposure to Cyclophosphamide Alters Cell-Cell Contacts and Activation of Embryonic Transcription in the Preimplantation Rat Embryo1. Biology of Reproduction. 63(1). 74–81. 19 indexed citations
16.
Harrouk, Wafa, et al.. (2000). Paternal exposure to cyclophosphamide induces DNA damage and alters the expression of DNA repair genes in the rat preimplantation embryo. Mutation Research/DNA Repair. 461(3). 229–241. 76 indexed citations
17.
Harrouk, Wafa, et al.. (2000). Paternal exposure to cyclophosphamide dysregulates the gene activation program in rat preimplantation embryos. Molecular Reproduction and Development. 57(3). 214–223. 2 indexed citations
18.
Harrouk, Wafa, et al.. (2000). Paternal exposure to cyclophosphamide dysregulates the gene activation program in rat preimplantation embryos. Molecular Reproduction and Development. 57(3). 214–223. 23 indexed citations
19.
Harrouk, Wafa & Hugh J. Clarke. (1995). Mitogen‐activated protein (MAP) kinase during the acquisition of meiotic competence by growing oocytes of the mouse. Molecular Reproduction and Development. 41(1). 29–36. 30 indexed citations
20.
Harrouk, Wafa & Hugh J. Clarke. (1993). Sperm chromatin acquires an activity that induces microtubule assembly during residence in the cytoplasm of metaphase oocytes of the mouse. Chromosoma. 102(4). 279–286. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amar V. Singh Breakdown of academic impact, for papers by Jackye Peretz Breakdown of academic impact, for papers by Costanza Rovida Breakdown of academic impact, for papers by Zhanquan Shi Breakdown of academic impact, for papers by Tzutzuy Ramı́rez Breakdown of academic impact, for papers by Diane M. Klotz Breakdown of academic impact, for papers by Dushyant Gulati Breakdown of academic impact, for papers by Gary J. Overmann Breakdown of academic impact, for papers by Jae‐Ho Shin Breakdown of academic impact, for papers by Fiona Sewell
Rankless by CCL
2026